Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P IVERSEN

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Ugeskrift for Laeger|October 29, 2010
Hepatharg TherapyP IVERSEN
Antisense Research and Development|January 1, 1993
INSERM/NIH Conference: antisense oligonucleotides and ribonucleases H, September, 1992P Iversen
Ugeskrift for Laeger|March 20, 1999
[Prostatic cancer--a disease with a new profile]P Iversen
Idrugs : the Investigational Drugs Journal|May 10, 2008
Antisense technologies--Cambridge Health Institute ConferenceP Iversen
European Urology|December 17, 1998
Orchidectomy and oestrogen therapy revisitedP Iversen
Scandinavian Journal of Urology and Nephrology|June 1, 1997
Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer GroupP Iversen
Anti-Cancer Drug Design|December 1, 1991
In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologueP Iversen
Ugeskrift for Laeger|January 16, 1989
[Severe toxic hepatitis during flutamide (Eulexin) treatment]S Møller, P Iversen
Ugeskrift for Laeger|August 13, 1998
[Radical prostatectomy for localized prostatic cancer]K Brasso, P Iversen
Hematological Oncology|January 1, 1994
Oligonucleotides in the treatment of leukemiaE Bayever, P Iversen
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Ugeskrift for Laeger|October 29, 2010
Hepatharg TherapyP IVERSEN
Antisense Research and Development|January 1, 1993
INSERM/NIH Conference: antisense oligonucleotides and ribonucleases H, September, 1992P Iversen
Ugeskrift for Laeger|March 20, 1999
[Prostatic cancer--a disease with a new profile]P Iversen
Idrugs : the Investigational Drugs Journal|May 10, 2008
Antisense technologies--Cambridge Health Institute ConferenceP Iversen
European Urology|December 17, 1998
Orchidectomy and oestrogen therapy revisitedP Iversen
Scandinavian Journal of Urology and Nephrology|June 1, 1997
Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer GroupP Iversen
Anti-Cancer Drug Design|December 1, 1991
In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologueP Iversen
Ugeskrift for Laeger|January 16, 1989
[Severe toxic hepatitis during flutamide (Eulexin) treatment]S Møller, P Iversen
Ugeskrift for Laeger|August 13, 1998
[Radical prostatectomy for localized prostatic cancer]K Brasso, P Iversen
Hematological Oncology|January 1, 1994
Oligonucleotides in the treatment of leukemiaE Bayever, P Iversen
Pageof 15